These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 5124593)

  • 21. Nonprescription drugs: an overview.
    Hodes B
    Int J Health Serv; 1974; 4(1):125-30. PubMed ID: 4829892
    [No Abstract]   [Full Text] [Related]  

  • 22. [Questions on the monitoring of drug consumption at the 7th International pharmaceutical Congress held in Paris, July 16-21, 1978].
    Stika L
    Cesk Zdrav; 1979 Jul; 27(7):320-4. PubMed ID: 36993
    [No Abstract]   [Full Text] [Related]  

  • 23. Cost-effectiveness of therapeutic drug monitoring.
    Vozeh S
    Clin Pharmacokinet; 1987 Sep; 13(3):131-40. PubMed ID: 3117472
    [No Abstract]   [Full Text] [Related]  

  • 24. Symposium on drug safety. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. The situation in the United Kingdom.
    Cahal DA
    Can Med Assoc J; 1968 Feb; 98(6):271-5. PubMed ID: 5636096
    [No Abstract]   [Full Text] [Related]  

  • 25. Monitoring of drugs after marketing.
    J R Coll Gen Pract; 1983 Jul; 33(252):438-41. PubMed ID: 6887114
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug regulation & therapeutic efficacy.
    Ritter JM
    Br J Clin Pharmacol; 2008 Jun; 65(6):801-2. PubMed ID: 18477262
    [No Abstract]   [Full Text] [Related]  

  • 27. Crying wolf on drug safety.
    Br Med J (Clin Res Ed); 1982 Jan; 284(6311):219-20. PubMed ID: 6799107
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug monitoring of surgical patients.
    Danielson DA; Porter JB; Dinan BJ; O'Connor PC; Lawson DH; Kellaway GS; Jick H
    JAMA; 1982 Sep; 248(12):1482-5. PubMed ID: 7109170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse drug reactions. A problem for drug regulatory agencies.
    Westerholm B
    Int J Clin Pharmacol; 1973 Apr; 7(2):183-9. PubMed ID: 4731286
    [No Abstract]   [Full Text] [Related]  

  • 30. Active Monitoring of Adverse Drug Reactions with Neural Network Technology.
    Wu T; Gao CC; Lin JS; Zha JL
    Chin Med J (Engl); 2017 Jun; 130(12):1498-1501. PubMed ID: 28584215
    [No Abstract]   [Full Text] [Related]  

  • 31. Adverse drug reactions: a pharmacist-based monitoring system.
    Gardner P; Watson LJ
    Clin Pharmacol Ther; 1970; 11(6):802-7. PubMed ID: 5481567
    [No Abstract]   [Full Text] [Related]  

  • 32. Statistical theory of prophylactic and therapeutic trials. I. Limitations of the unique null hypothesis.
    HOGBEN L; WRIGHTON R
    Br J Soc Med; 1952 Apr; 6(2):89-117. PubMed ID: 14935160
    [No Abstract]   [Full Text] [Related]  

  • 33. [Legal medicine aspects of current abuse potential].
    Kauert G; Eisenmenger W
    Versicherungsmedizin; 1993 Feb; 45(1):15-7. PubMed ID: 8438535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug surveillance: the role of the Committee on Safety of Medicines.
    Griffin JP
    Ulster Med J; 1972; 41(2):111-20. PubMed ID: 5084689
    [No Abstract]   [Full Text] [Related]  

  • 35. The Committee on Safety of Medicines.
    Goldberg A
    Health Bull (Edinb); 1981 Nov; 39(6):393-7. PubMed ID: 7035402
    [No Abstract]   [Full Text] [Related]  

  • 36. Play safe.
    Trans St Johns Hosp Dermatol Soc; 1972; 58(2):283-4. PubMed ID: 4665987
    [No Abstract]   [Full Text] [Related]  

  • 37. The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy.
    Simmons HE
    Int J Health Serv; 1974; 4(1):95-107. PubMed ID: 4829901
    [No Abstract]   [Full Text] [Related]  

  • 38. Statistical recognition of trends in health monitoring systems.
    Brockett PL; Kemperman JH
    Methods Inf Med; 1980 Apr; 19(2):106-12. PubMed ID: 7382832
    [No Abstract]   [Full Text] [Related]  

  • 39. The medical ethics of clinical therapeutic trials.
    de Wet BS
    S Afr Med J; 1973 Jan; 47(1):18-21. PubMed ID: 4686243
    [No Abstract]   [Full Text] [Related]  

  • 40. [Assessment of the quality and certification of biologically active synthetic and natural compounds].
    Popkov VA; Reshetniak VIu; Dugacheva GM
    Vestn Ross Akad Med Nauk; 1995; (10):39-44. PubMed ID: 8601090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.